Skip to main content
Premium Trial:

Request an Annual Quote

Gene DeFelice, Alexandra Snyder

Adaptive Biotechnologies has appointed Gene DeFelice to senior vice president and general counsel and Alexandra Snyder to translational medicine lead for Adaptive Research.

DeFelice has served as general counsel for several public healthcare and technology companies, including as primary counsel at Roche Diagnostics. He will join Adaptive's executive team to implement a legal infrastructure for clinical applications of next-generation sequencing technologies.

Snyder has joined Adaptive from Memorial Sloan Kettering Cancer Research Center where she specialized in tumor immunogenomics and response to checkpoint blockade immunotherapy.  

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.